SHORT MINI-FUTURE - BIOGEN IDEC | Market Closed - Deutsche Boerse AG 11:11:44 28/06/2024 pm IST | ||
| 12.55 EUR | -2.33% |
|
| Current month | -2.56% | ||
| 1 month | -7.52% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
BIOGEN INC.
Latest news about BIOGEN INC.
More news
| Date | Price | Change |
|---|---|---|
| 28/24/28 | 12.55 | -2.33% |
| 27/24/27 | 12.85 | -3.38% |
| 26/24/26 | 13.3 | +1.06% |
| 25/24/25 | 13.16 | +2.17% |
| 24/24/24 | 12.88 | -2.20% |
Delayed Quote Deutsche Boerse AG
Last update June 28, 2024 at 11:11 pm IST
More quotesStatic data
| Product type | Knock-Out with Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | BIOGEN INC. |
| Issuer | 
Vontobel
|
| WKN | VV7ELD |
| ISIN | DE000VV7ELD5 |
| Date issued | 29/09/2022 |
| Strike | 364.2 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 9.32 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 16.27 € |
|---|---|
| Lowest since issue | 3.68 € |
Company Profile
Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows:
- sales of medicines (73,7%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.;
- royalties (17,2%) ;
- other (9,1%): primarily revenues from partnership agreements.
Sector
-
Consensus: Biogen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
35
Last Close Price
231.8
USD
Average target price
283.2
USD
Spread / Average Target
+22.14%
- Stock Market
- Certificates
- Certificat
